A case of myelolipoma with bilateral adrenal hyperaldosteronism cured after unilateral adrenalectomy

Internal Medicine

Volumn 51, Issue 5, 2012, Pages 479-485

  Inuzuka, Megumi ^a   Tamura, Naohisa ^a   Sone, Masakatsu ^a   Taura, Daisuke ^a   Sonoyama, Takuhiro ^a   Honda, Kyoko ^a   Kojima, Katsutoshi ^a   Fukuda, Yorihide ^a   Ueda, Yoriko ^a   Yamashita, Yui ^a   Kondo, Eri ^a   Yamada, Go ^a   Fujii, Toshihito ^a   Miura, Masako ^a   Kanamoto, Naotetsu ^a   Yasoda, Akihiro ^a   Arai, Hiroshi ^a   Mikami, Yoshiki ^a   Sasano, Hironobu ^b   Nakao, Kazuwa ^a  

^a KYOTO UNIVERSITY   (Japan)

^b TOHOKU UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Aldosterone releasing factor; Bilateral adrenal hyperplasia; Myelolipoma; Primary aldosteronism

Indexed keywords

3 (OR 17) BETA HYDROXYSTEROID DEHYDROGENASE; 6BETA IODOMETHYL 19 NORCHOLEST 5 (10) EN 3BETA OL I 131; AMLODIPINE; CANDESARTAN HEXETIL; CAPTOPRIL; CORTICOTROPIN; DOXAZOSIN MESYLATE; FUROSEMIDE; NIFEDIPINE; SPIRONOLACTONE; TELMISARTAN; UNCLASSIFIED DRUG;

ADRENAL CORTEX ADENOMA; ADRENAL SCINTISCANNING; ADRENALECTOMY; ADULT; ALDOSTERONE BLOOD LEVEL; ARTICLE; BODY WEIGHT; CARDIOMEGALY; CASE REPORT; COMPUTER ASSISTED TOMOGRAPHY; CONTROLLED DRUG RELEASE; DEXAMETHASONE SUPPRESSION TEST; DISEASE ASSOCIATION; DRUG DOSE INCREASE; DRUG DOSE REDUCTION; DRUG WITHDRAWAL; ELECTROCARDIOGRAPHY; HEART LEFT VENTRICLE HYPERTROPHY; HUMAN; HUMAN TISSUE; HYPERTENSION; MALE; MICROSCOPY; MYELOLIPOMA; NUCLEAR MAGNETIC RESONANCE IMAGING; PLASMA RENIN ACTIVITY; PRIMARY HYPERALDOSTERONISM; RASH; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM; THORAX RADIOGRAPHY;

ADRENAL GLAND NEOPLASMS; ADRENALECTOMY; ALDOSTERONE; COMORBIDITY; HUMANS; HYPERALDOSTERONISM; HYPERTENSION; MALE; MIDDLE AGED; MYELOLIPOMA; OBESITY; TREATMENT OUTCOME;

EID: 84857843964     PISSN: 09182918     EISSN: 13497235     Source Type: Journal    
DOI: 10.2169/internalmedicine.51.5777     Document Type: Article

References (23)

1. Lam KY, Lo CY. Adrenal lipomatous tumours: a 30 year clinicopathological experience at a single institution. J Clin Pathol 54: 707-712, 2001.
2. Ueshiba H. Incidence of adrenal hypertension in adrenal incidentaloma. Nippon Naika Gakkai Zasshi (The Journal of the Japanese Society of Internal Medicine) 95: 629-633, 2006 (in Japanese, Abstract in English).
3. Hisamatsu H, Sakai H, Tsuda S, Shigematsu K, Kanetake H. Combined adrenal adenoma and myelolipoma in a patient with Cushing's syndrome: case report and review of the literature. Int J Urol 11: 416-418, 2004.
4. Matsuda T, Abe H, Takase M, et al. Case of combined adrenal cortical adenoma and myelolipoma. Pathol Int 54: 725-729, 2004.
5. Manassero F, Pomara G, Rappa F, Cuttano MG, Crisci A, Selli C. Adrenal myelolipoma associated with adenoma. Int J Urol 11: 326-328, 2004.
6. Sasano H, Masuda T, Ojima M, Fukuchi S, Sasano N. Congenital 17 alpha-hydroxylase deficiency: a clinicopathologic study. Hum Pathol 18: 1002-1007, 1987.
7. Mermejo LM, Elias Junior J, Saggioro FP, et al. Giant adrenal myelolipoma associated with 21-hydroxylase deficiency: unusual association mimicking an androgen-secreting adrenocortical carcinoma. Arq Bras Endocrinol Metabol 54: 419-424, 2010.
8. John M, Menon SK, Shah NS, Menon PS. Congenital adrenal hyperplasia 11beta-hydroxylase deficiency: two cases managed with bilateral adrenalectomy. Singapore Med J 50: e68-e70, 2009.
9. Ogihara T, Kikuchi K, Matsuoka H, et al. The Japanese Society of Hypertension Guidelines for the Management of Hypertension (JSH 2009). Hypertens Res 32: 3-107, 2009.
10. Yamahara K, Itoh H, Yamamoto A, et al. New diagnostic procedure for primary aldosteronism: adrenal venous sampling under adrenocorticotropic hormone and angiotensin II receptor blocker-- application to a case of bilateral multiple adrenal microadenomas. Hypertens Res 25: 145-152, 2002.
11. Omura M, Sasano H, Saito J, Yamaguchi K, Kakuta Y, Nishikawa T. Clinical characteristics of aldosterone-producing microadenoma, macroadenoma, and idiopathic hyperaldosteronism in 93 patients with primary aldosteronism. Hypertens Res 29: 883-889, 2006.
12. Satoh F, Abe T, Tanemoto M, et al. Localization of aldosteroneproducing adrenocortical adenomas: significance of adrenal venous sampling. Hypertens Res 30: 1083-1095, 2007.
13. Nishikawa T, Omura M, Satoh F, et al. Guidelines for the diagnosis and treatment of primary aldosteronism-The Japan Endocrine Society 2009. Endocr J advance publication Aug. 9, 2011 doi: 10.1507/endocrj. EJ11-0133.
14. Funder JW, Carey RM, Fardella C, et al. Case detection, diagnosis, and treatment of patients with primary aldosteronism: an Endocrine Society clinical practice guideline. J Clin Endocrinol Metab 93: 3266-3281, 2008.
15. Olsson CA, Krane RJ, Klugo RC, Selikowitz SM. Adrenal myelolipoma. Surgery 73: 665-670, 1973.
16. Escuin F, Gomez P, Martinez I, Perez-Fontan M, Selgas R, Sanchez-Sicilia L. Angiomyelolipoma associated with bilateral adrenocortical hyperplasia and hypertension. J Urol 133: 655-657, 1985.
17. Rossi GP, Belfiore A, Bernini G, et al. Body mass index predicts plasma aldosterone concentrations in overweight-obese primary hypertensive patients. J Clin Endocrinol Metab 93: 2566-2571, 2008.
18. Engeli S, Bohnke J, Gorzelniak K, et al. Weight loss and the renin-angiotensin-aldosterone system. Hypertension 45: 356-362, 2005.
19. Ehrhart-Bornstein M, Lamounier-Zepter V, Schraven A, et al. Human adipocytes secrete mineralocorticoid-releasing factors. Proc Natl Acad Sci USA 100: 14211-14216, 2003.
20. Krug AW, Vleugels K, Schinner S, et al. Human adipocytes induce an ERK1/2 MAP kinases-mediated upregulation of steroidogenic acute regulatory protein (StAR) and an angiotensin IIsensitization in human adrenocortical cells. Int J Obes (Lond) 31: 1605-1616, 2007.
21. Belz GG, Breithaupt-Grogler K, Butzer R, Fuchs W, Hausdorf C, Mang C. The pharmacological potency of various AT1 antagonists assessed by Schild regression technique in man. J Renin Angiotensin Aldosterone Syst 1: 336, 2000.
22. Rao P, Kenney PJ, Wagner BJ, Davidson AJ. Imaging and pathologic features of myelolipoma. Radiographics 17: 1373-1385, 1997.
23. Wulf GG, Jahns-Streubel G, Strutz F, et al. Paraneoplastic hypokalemia in acute myeloid leukemia: a case of renin activity in AML blast cells. Ann Hematol 73: 139-141, 1996.